本報(bào)道最初發(fā)表于Endpoints News。請點(diǎn)擊這里查看原文
A high-dose version of Innovent Biologics’ obesity drug led to patients with moderate-to-severe disease losing 18.6% of their body weight in about a year and two months, according to data from a late-stage China-based trial.
根據(jù)一項(xiàng)在中國開展的晚期臨床試驗(yàn)數(shù)據(jù)顯示，信達(dá)生物(Innovent Biologics)的肥胖癥藥物高劑量版本使中重度患者在約14個(gè)月內(nèi)平均減重18.6%。
您已閱讀10%（335字），剩余90%（3134字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。